Leveraging near-term Incyte catalysts by adding call options to Volatility Portfolio

Leveraging near-term Incyte catalysts by adding call options to Volatility Portfolio

This page is for Subscribers.

We’ll share all of our Posts and our Live Public Portfolios with you!

Sign Up for a subscription and you can view everything on the Juggling With Knives website. (If you’ve purchased the book, you’ve earned a free subscription. Use the Coupon Code in the book to start your one-year FREE subscription).

Plus, you’ll get Jim’s Volatility Email Update each evening at 8:00pm.

SignUpButton200

Nektar blows away revenue projections, gives very positive guidance on drug pipeline

Nektar blows away revenue projections, gives very positive guidance on drug pipeline

This page is for Subscribers.

We’ll share all of our Posts and our Live Public Portfolios with you!

Sign Up for a subscription and you can view everything on the Juggling With Knives website. (If you’ve purchased the book, you’ve earned a free subscription. Use the Coupon Code in the book to start your one-year FREE subscription).

Plus, you’ll get Jim’s Volatility Email Update each evening at 8:00pm.

SignUpButton200

Nektar blows away revenue projections, gives very positive guidance on drug pipeline

To rebalance my Volatility Portfolio I’m selling my Nektar May 18 call options

I'm not complaining, mind you. As of Friday February 23, the Nektar Therapeutics May 18, 2018 call options with a strike of $26 (NKTR180518C00026000) in my Volatility Portfolio were up 2546% from my November 1, 2017 buy at $2.40 to $63.50. But I don't want to have such an overpowering position in one stock or option overwhelm the rest of this portfolio. So in my post on rebalancing this portfolio I said I would sell this call option

This page is for Subscribers.

We’ll share all of our Posts and our Live Public Portfolios with you!

Sign Up for a subscription and you can view everything on the Juggling With Knives website. (If you’ve purchased the book, you’ve earned a free subscription. Use the Coupon Code in the book to start your one-year FREE subscription).

Plus, you’ll get Jim’s Volatility Email Update each evening at 8:00pm.

SignUpButton200

Big earnings report from MGM Resorts before the market open tomorrow

Big earnings report from MGM Resorts before the market open tomorrow

This page is for Subscribers.

We’ll share all of our Posts and our Live Public Portfolios with you!

Sign Up for a subscription and you can view everything on the Juggling With Knives website. (If you’ve purchased the book, you’ve earned a free subscription. Use the Coupon Code in the book to start your one-year FREE subscription).

Plus, you’ll get Jim’s Volatility Email Update each evening at 8:00pm.

SignUpButton200

How to use my portfolios

How to use my portfolios

This page is for Subscribers.

We’ll share all of our Posts and our Live Public Portfolios with you!

Sign Up for a subscription and you can view everything on the Juggling With Knives website. (If you’ve purchased the book, you’ve earned a free subscription. Use the Coupon Code in the book to start your one-year FREE subscription).

Plus, you’ll get Jim’s Volatility Email Update each evening at 8:00pm.

SignUpButton200

Nektar blows away revenue projections, gives very positive guidance on drug pipeline

Bristol-Myers puts up potential $3.6 billion in deal for 35% of a Nektar cancer drug

This page is for Subscribers.

We’ll share all of our Posts and our Live Public Portfolios with you!

Sign Up for a subscription and you can view everything on the Juggling With Knives website. (If you’ve purchased the book, you’ve earned a free subscription. Use the Coupon Code in the book to start your one-year FREE subscription).

Plus, you’ll get Jim’s Volatility Email Update each evening at 8:00pm.

SignUpButton200